Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies

NCT01705847

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: VU Medical Center (VUmc) Amsterdam, Netherlands

Academic Medical Center Amsterdam, Netherlands

St. Antonius Hospital Nieuwegein, Netherlands

Erasmus MC - Daniel den Hoed Cancer Center Rotterdam, Netherlands

View Trial Details

Completed

A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

NCT01950364

Conditions: Anaplastic Large-Cell Lymphoma, Disease Attributes, Hematologic Diseases, +16 more
Locations: Brussels, Belgium

Ghent, Belgium

Vilnius, Lithuania

Barcelona, Spain

View Trial Details

Completed

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

NCT00644124

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Sanofi-Aventis Administrative Office Paris, France

View Trial Details

Completed

Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant

NCT01904175

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202

NCT00896662

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +30 more
Locations: Not specified

View Trial Details

Completed

Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)

NCT00842114

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Hospital Universitario de La Princesa Madrid, Spain

View Trial Details

Completed

A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)

NCT02723071

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Melbourne, Australia

Perth, Australia

Woolloongabba, Australia

Edmonton, Alberta, Canada

View all 23 locations

View Trial Details

Completed

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

NCT00293384

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +112 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies

NCT00472056

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma

NCT01466881

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +23 more
Locations: Providence Hospital Mobile, Alabama, United States

The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States

The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States

The University of Arizona Medical Center-University Campus Tucson, Arizona, United States

View all 161 locations

View Trial Details